Tag Archives: Major

Hackensack Meridian School of Medicine at Seton Hall University Launches Grant Program to Help Deliver Breakthroughs in Treatment of Major Diseases and Conditions – Seton Hall University News & Events

The Hackensack Meridian School of Medicine at Seton Hall University is proud to announce a $ 100,000 program to support network physicians and researchers working to develop novel treatments for some of the most costly and challenging diseases and conditions including diabetes, depression and epilepsy. The newly launched Research Pilot Project Funding Program is supported… Read More »

What are the symptoms to major depression

It represents a significant section of what population, mDD can be devastating. Especially major combination with other symptoms, depressed mood may are require professional treatment, learn more about depression so you can talk openly with your doctor. On the other hand, the symptoms of depression can be complex and vary the between people. Although depression can… Read More »

McGill study identifies new role of major genetic risk factor in Alzheimer’s disease

For years, physicians have been aware that patients carrying the apolipoprotein ꜫ4 (APOE ꜫ4) gene are at a greater risk of developing Alzheimer’s disease. New research from McGill University has now found the gene plays an even greater role in dementia. In a study published today in the Journal of the American Medical Association: Neurology, Dr. Pedro… Read More »

Fewer in US See Health System as Having Major Problems – Gallup

Story Highlights 63% say healthcare system is in state of crisis or has major problems Negative ratings of system at lowest point since 2002 Negative views of U.S. healthcare continue to drop among Republicans WASHINGTON, D.C. — Sixty-three percent of Americans describe the U.S. healthcare system as being in a “state of crisis” (14%) or… Read More »

ADVANCE study shows high frequency of major weight gain in women receiving dolutegravir with TAF

Metabolic syndrome – including obesity – developed significantly more frequently in people who received dolutegravir, tenofovir alafenamide (TAF) and emtricitabine compared to other regimens in the South African ADVANCE study, Michelle Moorhouse reported on Thursday at the 17th European AIDS Conference in Basel, Switzerland. Furthermore, updated follow-up from the study showed that close to 60%… Read More »